Indoco Remedies P/E Ratio

Indoco Remedies P/E ratio. Indoco Remedies (INDOCO) P/E ratio is not applicable — EPS (TTM) ₹-10.70. See Healthcare peers with valid P/E ratios below.

P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable

Company reported a loss in the most recent quarter. P/E ratio is not meaningful for loss-making periods.

Current EPS: ₹-10.70

Recent Quarterly Performance

Quarter EPS (₹) Net Profit (₹ Cr) Status
Sept 2026 2.11 20 Profit
Mar 2026 -2.57 -24 Loss
Jun 2026 7.09 65 Profit
Sept 2025 -1.00 -9 Loss
Mar 2025 -4.48 -41 Loss
Jun 2025 -3.94 -36 Loss
Dec 2025 -3.20 -30 Loss
Sept 2024 -1.09 -10 Loss

Healthcare Peers with Valid P/E Ratios — INDOCO Comparison

Healthcare sector average P/E 52.14, median 29.4 — INDOCO excluded (negative EPS).

Sector Average PE
52.14
Sector Median PE
29.4
Lowest PE
2.0
Profitable Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low

Related Analysis